GET THE APP

Drug Designing: Open Access

ISSN - 2169-0138

Metformin

Metformin and other biguanides may antagonize the action of glucagon, thus reducing fasting glucose levels. Metformin also induces a profound shift in the faecal microbial community profile in diabetic mice and this may contribute to its mode of action possibly through an effect on glucagon-like peptide-1 secretion.

Relevant Topics in Pharmaceutical Sciences

Top